I parallel designede kliniske undersøgelser, der omfattede 244 patienter i hæmodialyse, som var i behandling i op til 54 uger samt 97 patienter i en 12 ugers lang peritoneal dialysebehandling, var de hyppigst forekommende bivirkninger (≥ 5% af patienterne), der muligvis eller sandsynligvis var relaterede til Renagel, alle i systemorgan klassen ” gastrointestinale sygdomme ”.
In parallel design studies involving 244 haemodialysis patients with treatment duration of up to 54 weeks and 97 peritoneal dialysis patients with treatment duration of 12 weeks, the most frequently occurring (≥ 5% of patients) undesirable effects possibly or probably related to Renagel were all in the gastrointestinal disorders system organ class.